Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-01-05 @ 8:25 PM
Study NCT ID:
NCT00470067
Status:
TERMINATED
Last Update Posted:
2014-08-22
First Post:
2007-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-03
First Submit QC Date:
None
Study First Post Date:
2007-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-27
Results First Submit QC Date:
None
Results First Post Date:
2014-08-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-08
Last Update Post Date:
2014-08-22
Last Update Post Date Type:
ESTIMATED